Grafton Therapeutics Sàrl

Grafton Therapeutics Sàrl, limited liability company in Saint-Prex (VD), research. Registration active in the commercial register. Latest publication: June 8, 2023. UID CHE-358.594.819.

Grafton Therapeutics develops high-affinity dual SSTR2-SSTR5 agents and novel radiopharmaceuticals for targeted treatment of somatostatin receptor-positive tumors. Its medicine candidates and approaches are at the preclinical stage, with SMTR-002 identified for further studies.¹

Commercial register

Legal form: Limited liability company Sàrl/GmbH
Registered office: c/o CDC Avocats Sàrl Chemin de Beaufort 12, 1162 St-Prex
Share capital: CHF 20,000
UID: CHE-358.594.819
Former names: SomTheranostics Sàrl
Registered purpose (original language): La société a pour but la recherche et le développement de diagnostics et de thérapies en oncologie, endocrinologie et gastroentérologie (pour but complet cf. statuts).

Prospex data

Sector: Scientific research and development¹
Website: With an account
Officers: With an account
Headcount: With an account
Signals: With an account

Get an email when Grafton Therapeutics Sàrl changes

Whenever this company's commercial register entry changes, we send you the publication. Free, no account.

An account opens each locked row: the website, the officers, the headcount and every signal for Grafton Therapeutics Sàrl, the last 90 days included.

Create a free account

All 4 companies registered at this address

Similar companies

Orion Biotechnology Holding SA Genève Financial service activities, except insurance and pension funding
ORION Biotechnology Switzerland Sàrl Genève Manufacture of basic pharmaceutical products
Adoram Therapeutics SA Lancy Wholesale trade
Pilatus Biosciences SA Epalinges Scientific research and development

A free account opens every company that looks like Grafton Therapeutics Sàrl, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Name changed June 8, 2023

SomTheranostics Sàrl, à Saint-Prex, CHE-358.594.819 (FOSC du 04.10.2021, p. 0/1005304388). Statuts modifiés le 25.04.2023. Nouvelle raison de commerce: Grafton Therapeutics Sàrl.
Officers changed Oct. 4, 2021

SomTheranostics Sàrl, à Saint-Prex, CHE-358.594.819 (FOSC du 23.09.2019, p. 0/1004721926). Porchet Hervé n'est plus gérant; sa signature est radiée. Harris Alan, qui n'est plus président, est nommé directeur général. Signature individuelle est conférée à Cottier Nicolas, de Jaun, à Saint-Prex, directeur.
Address changed · Seat moved Sept. 23, 2019

SomTheranostics Sàrl, à Cugy (VD), CHE-358.594.819 (FOSC du 23.02.2017, p. 0/3367149). Statuts modifiés le 6 septembre 2019. Siège transféré à Saint-Prex. Nouvelle adresse: Chemin de Beaufort 12, c/o CDC Avocats Sàrl, 1162 St-Prex.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.